Holen Sie sich die Stockscreener-App
34.51
2.53%
0.85
Handel nachbörslich:
34.51
Schlusskurs vom Vortag:
$33.66
Offen:
$33.55
24-Stunden-Volumen:
28,298
Relative Volume:
1.77
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.71%
1M Leistung:
+10.42%
6M Leistung:
+90.66%
1J Leistung:
+32.11%
1-Tages-Spanne:
$33.20
$34.96
1-Wochen-Bereich:
$32.16
$35.40
52-Wochen-Spanne:
$13.42
$35.40
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Firmenname
Virtus Lifesci Biotech Clinical Trials Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
34.51 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
323.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
659.03 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
662.28 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
247.26 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
590.07 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Aktie (BBC) Neueste Nachrichten
Is Virtus LifeSci Biotech Clinical Trials stock ideal for retirement investors - newser.com
Is Virtus LifeSci Biotech Clinical Trials stock positioned for digital growth eraWeekly Trade Report & Low Risk Investment Opportunities - newser.com
Will Virtus LifeSci Biotech Clinical Trials stock profit from AI boom2025 Short Interest & Daily Profit Focused Screening - newser.com
Best-Performing ETFs of Last Week - sharewise.com
Understanding Momentum Shifts in (BBC) - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (BBC) Movement - news.stocktradersdaily.com
Biotech ETF (BBC) Hits New 52-Week High - MSN
Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock price, news, quote and history - Yahoo! Finance UK
Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Can Virtus LifeSci Biotech Clinical Trials stock deliver strong annual returns2025 Pullback Review & Fast Entry Momentum Alerts - nchmf.gov.vn
Discipline and Rules-Based Execution in BBC Response - news.stocktradersdaily.com
Trade War or Not, Specific Industry ETFs Are in Sweet Spots - TradingView
What MACD trends signal for Virtus LifeSci Biotech Clinical Trials stockWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Will Virtus LifeSci Biotech Clinical Trials stock return to pre crash levelsMarket Movers & Proven Capital Preservation Methods - newser.com
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC - sharewise.com
Canadian Equities Shine: ETFs to Capture the Momentum - The Globe and Mail
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
(BBC) Trading Signals - news.stocktradersdaily.com
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - Nasdaq
6 Best-Performing ETFs of Last Week - Yahoo Finance
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - Seeking Alpha
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - Nasdaq
Virtus LifeSci Biotech Clinical Trials ETF (BBC) Stock Trends and Sentiment 2025 - MarketBeat
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
ALPS’ Biotech ETF SBIO Week’s Top Performer - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech Wins Last Week: 5 Best ETFs - Yahoo Finance
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal - ETF Trends
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Zacks Investment Research
Biotech ETFs Are Making a Comeback - ETF Trends
Biotech ETF Tops in June: 5 Stocks That Outperform - Zacks Investment Research
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point - ETF Trends
How to Pick a Biotech ETF - Investment U
Make Biotech Cash Considerations With SBIO - ETF Trends
Biotech Stocks and ETFs Starting to Look Healthier - ETF Database
Some Biotech Stocks Are Now Cheap - ETF Trends
Small-Cap Biotech Opportunity Is Knocking - ETF Database
Finanzdaten der Virtus Lifesci Biotech Clinical Trials Etf-Aktie (BBC)
Es liegen keine Finanzdaten für Virtus Lifesci Biotech Clinical Trials Etf (BBC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):